A US study, based on data analysis of millions of people, concluded that Sildenafil, known commercially as “Viagra”, could significantly reduce the risk of Alzheimer’s disease.

A team of researchers from the Cleveland Clinic analyzed health data from more than 7.2 million people and found that people who took the drug, originally designed to treat erectile dysfunction, were 69% less likely to develop Alzheimer’s disease, compared to those who did not use the pill.

This is not the first time that Viagra has been linked to health benefits for diseases other than erectile dysfunction.

In the new study, the researchers looked at the types of drugs approved by the US Food and Drug Administration (FDA) that might hypothetically help treat Alzheimer’s, and found that Sildenafil is one of the best drugs approved by the agency out of more than 1,600 types of drugs.

But researchers have warned against drawing a causal link from this result, and they plan to conduct randomized clinical trials to confirm this.

By Editor

Leave a Reply